HBIO — Harvard Bioscience Inc

Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on NASDAQ. It is led by James W. Green, based in 84 October Hill Road, Holliston, MA, United States, 01746, with about 330 employees. Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Latest reported HBIO revenue for 2025-09-30 was $20.6M. Net income was -$1.2M. Revenue was up 0.7% from 2025-06-30 to 2025-09-30. HBIO currently screens at market cap $20.3M.

Use this HBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Harvard Bioscience Inc even when a live quote feed is slow.